E-cadherin in gastric carcinomas related to histological prognostic parameters

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 3 SUPPL., 2012, Pages 1107-1112

  Stǎnculescu, Diana ^a   Mǎrgǎritescu, Cl ^a   Stepan, A ^a   Mitruţ, Anca Oana ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

E cadherin; Gastric carcinomas; Prognostic indicators

Indexed keywords

EID: 84865788714     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cabebe EC, Mehta VK, Fisher G, Gastric cancer, eMedicine Specialties, Oncology, Carcinomas of the Gastrointestinal Tract, Updated: Jul 21, 2008.
2. Carl-McGrath S, Ebert M, Röcken Ch, Gastric adenocarcinoma: epidemiology, pathology and pathogenesis, Cancer Therapy, 2007, 5:877-894.
3. Lauren P, The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. An attempt at histo-clinical classification, Acta Pathol Microbiol Scand, 1965, 64:31-49.
4. Satoh S, Kawashima K, Matsumoto S, Hasegawa S, Okabe H, Nomura A, Yoshibayashi H, Watanabe G, Nagayama S, Fukushima M, Sakai Y, Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer, Chemotherapy, 2007, 53(3):226-232.
5. Peek RM Jr, Blaser MJ, Helicobacter pylori and gastrointestinal tract adenocarcinomas, Nat Rev Cancer, 2002, 2(1):28-37.
6. Charalabopoulos K, Papalimneou V, Evangelou A, Kalfakakou V, Kiortsis D, Kolettas E, Alamanos J, Charalabopoulos A, Agnantis NJ, Is the E-cadherin downregulation observed in Helicobacter pylori infection associated with gastric cancer development? An additional element in the disease jigsaw, Exp Oncol, 2003, 25(4):270-273.
7. Shun CT, Wu MS, Lin MT, Chang MC, Lin JT, Chuang SM, Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection, Oncology, 2001, 60(4):339-345.
8. Mareel M, Bracke M, Van Roy F, Invasion promotor versus invasion suppressor molecules: the paradigm of E-cadherin, Mol Biol Rep, 1994, 19(1):45-67.
9. Wang Q, Gu D, Wang M, Zhang Z, Tang J, Chen J, The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans, DNA Cell Biol, 2011, 30(6):395-400.
10. Almeida PR, Ferreira VA, Santos CC, Rocha-Filho FD, Feitosa RR, Falcão EA, Cavada BK, Ribeiro RA, E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes, J Clin Pathol, 2010, 63(7):635-639.
11. Birchmeier W, Behrens J, Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness, Biochim Biophys Acta, 1994, 1198(1):11-26.
12. Takeichi M, Cadherins in cancer: implications for invasion and metastasis, Curr Opin Cell Biol, 1993, 5(5):806-811.
13. Chan AO, E-cadherin in gastric cancer, World J Gastroenterol, 2006, 12(2):199-203.
14. Polakis P, Wnt signaling and cancer, Genes Dev, 2000, 14(15):1837-1851.
15. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H, E-cadherin gene mutations provide clues to diffuse type gastric carcinomas, Cancer Res, 1994, 54(14):3845-3852.
16. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S, E-cadherin gene mutations in signet ring cell carcinoma of the stomach, Jpn J Cancer Res, 1996, 87(8):843-848.
17. Christofori G, Semb H, The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene, Trends Biochem Sci, 1999, 24(2):73-76.
18. Graziano F, Humar B, Guilford P, The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice, Ann Oncol, 2003, 14(12):1705-1713.
19. Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S, Becke H, Hutzler P, Birchmeier W, Höfler H, Becker KF, Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility, Oncogene, 1999, 18(30):4301-4312.
20. Park JM, Jang YJ, Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Gastric cancer histology: clinicopathologic characteristics and prognostic value, J Surg Oncol, 2008, 98(7):520-525.
21. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I, E-cadherin expression in primary and metastatic gastric cancer: downregulation correlates with cellular dedifferentiation and glandular disintegration, Cancer Res, 1993, 53(7):1690-1695.
22. Shimoyama Y, Hirohashi S, Expression of E- and Pcadherin in gastric carcinomas, Cancer Res, 1991, 51(8):2185-2192.
23. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF, Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance, World J Gastroenterol, 2004, 10(20):3044-3047.
24. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, Hommel G, Prognostic value of E-cadherin expression in 413 gastric carcinomas, Int J Cancer, 1996, 69(3):184-189.
25. Hirohashi S, Inactivation of the E-cadherin-mediated cell adhesion system in human cancers, Am J Pathol, 1998, 153(2):333-339.
26. Shino Y, Watanabe A, Yamada Y, Tanase M, Yamada T, Matsuda M, Yatnashita J, Tatsumi M, Miwa T, Nakano H, Clinicopathologic evaluation of immunohistochemical Ecadherin expression in human gastric carcinomas, Cancer, 1995, 76(11):2193-2201.
27. Graziano F, Arduini F, Ruzzo A, Bearzi I, Humar B, More H, Silva R, Muretto P, Guilford P, Testa E, Mari D, Magnani M, Cascinu S, Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, nodepositive, diffuse gastric cancer, Clin Cancer Res, 2004, 10():2784-2789.
28. Machado JC, Carneiro F, Beck S, Rossi S, Lopes J, Taveira-Gomes A, Cardoso-Oliveira M, E-cadherin expression is correlated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma, Int J Surg Pathol, 1998, 6(3):135-144.